BAFF plays an important role in the pathogenesis of various autoimmune diseases including systemic lupus erythematosus, and the anti-BAFF antibody belimumab has been approved as a treatment for systemic lupus erythematosus (Vincent et al., 2014). Here, TNFSF13B is linked to systemic lupus erythematosus.